- 952.876.4057
- 952.876.4058
- M-F, 9:00am – 5:00pm
The PARI VORTEX® is an affordable valve-holding chamber that minimizes the technique and coordination needed for effective inhaler treatments.
Designed with non-electrostatic technology, VORTEX® delivers 56% more respirable particles compared to traditional plastic holding chambers and spacers. Now patients of all ages are assured a more efficient and consistent medication dose from their MDI, resulting in optimal treatments and a better quality of life.
Video:
Medication deposited in the throat with MDI alone vs. MDI with VORTEX1
Key Findings:
VORTEX® significantly reduces medication deposition in the mouth and back of the throat, which may cause unwanted side effects, vs. MDI alone.
MDI alone vs. VORTEX® with MDI vs. Optichamber Diamond with MDI1
Key Findings:
VORTEX® delivers a higher respirable drug dose than MDI alone and OptiChamber Diamond.
1Measurements according to Ph. Eur. 2.9.18 and USP 601: Next Generation Impactor; const. flow 30l/min; 50 ± 5 % relative humidity and 23 ± 2 °C: 3 test devices each measured in triplicates (n=3×3=9); pMDI Sultanol® (100μg Salbutamol, GlaxoSmithKline);
* All registered marks and trademarks belong to their respective companies
(1) VORTEX Holding Chamber (Spacer)
Mask Available upon request with your order.
The Difference is in the Delivery1
VORTEX significantly reduces oropharyngeal deposition, which may cause unwanted side effects, vs. MDI alone.
1Measurements according to Ph. Eur. 2.9.18 and USP 601: Next Generation Impactor; const. flow 30l/min; 50 ± 5 % relative humidity and 23 ± 2 °C: 3 test devices each measured in triplicates (n=3×3=9); pMDI Sultanol® (100μg Salbutamol, GlaxoSmithKline);
* All registered marks and trademarks belong to their respective companies
| Configuration | Part # | NDC # | HCPCS # |
|---|---|---|---|
| VORTEX® Valved Holding hamber | 051F7000 | 83490-0510-35 | A4627 |
| VORTEX® with Chloe Ladybug | 051F7100 | 83490-0510-37 | A4627 |
| VORTEX® with Felix Frog | 051F7200 | 83490-0510-39 | A4627 |
1Zuberhuhler P, et al. In vitro testing of new non-electrostatic holding chamber with hydrofluoralkane salbutamol and beclomethasone inhalers. CHEST 2002; 122:185S.
2Wildhaber JH, et al. Effects of electrostatic charge, flow delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants. Thorax 1996; 51:985-988.
